Polar Securities Inc. 13D and 13G filings for Calidi Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 06:53 am Purchase |
2023-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI |
Polar Securities Inc. | 229,009 6.100% |
187,729 (+454.77%) |
Filing |
| 2023-02-09 6:29 pm Sale |
2022-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI |
Polar Securities Inc. | 41,280 10.000% |
-156,720 (-79.15%) |
Filing |
| 2022-02-08 11:07 am Purchase |
2021-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI |
Polar Securities Inc. | 198,000 8.610% |
198,000 (New Position) |
Filing |